TRANSITION AGREEMENTTransition Agreement • February 26th, 2021 • Gossamer Bio, Inc. • Pharmaceutical preparations • California
This Transition Agreement (the “Agreement”) is entered into by and among Sheila Gujrathi, M.D. (“Executive”), Gossamer Bio Services, Inc. (the “Gossamer Services”), and Gossamer Bio, Inc. (“Parent,” and together with Gossamer Services, collectively the “Company”), effective as of the Effective Date (as defined below).
Gossamer Bio, Inc. Gossamer Bio Services, Inc.Letter Agreement • February 26th, 2021 • Gossamer Bio, Inc. • Pharmaceutical preparations • California
The purpose of this letter agreement (this “Agreement”) is to memorialize the terms and conditions of your employment as President and Chief Executive Officer of Gossamer Bio, Inc. (“Parent”) and continued service as Chairman of the Board of Directors (the “Board”) of Parent. Effective as of November 16, 2020 (the “Effective Date”), you will be employed by Gossamer Bio Services, Inc. (“Gossamer Services”, a wholly-owned subsidiary of Parent, and together with Parent, collectively the “Company”), on a full-time basis, as its President and Chief Executive Officer and to serve as an officer with those same positions of Parent, working out of the Company’s headquarters located in San Diego, California. You shall have all the duties, responsibilities and authority commensurate with these positions, subject to the supervision of, and reporting directly to, the Board. This Agreement supersedes and replaces that certain letter agreement dated June 3, 2019, between you and the Company (the “Ori
